# Treatment: becaplermin (PDGF-BB) -- recombinant growth factor
# Literature: FDA-approved for DFU; Steed 2006, Smiell 1998
# Mechanism: potent fibroblast mitogen and chemoattractant, macrophage recruitment
[skin.diabetic]
fibroblast_activation_factor = 1.0 # 2.0 -> 1.0: PDGF-BB chemotaxis activates fibroblasts rapidly
migration_factor = 0.75            # 0.45 -> 0.75: modest boost via growth factor signaling

[skin.fibroblast]
density_factor = 1.8               # 1.0 -> 1.8: 1.9x mitogenic effect on fibroblasts
